News

The European Commission has taken decision to extend the transitional period for a period of three years, which was determined in the context of the action of the medicine verification system regarding the medicine products exported to the United Kingdom* (UK) following its’ withdrew from the European Union.

In 2021 the Latvian Medicines Verification System has been operating stably, constantly ensuring the verification of medicines that are available to the Latvian population through legal supply chains, according to the annual report 2021 of the Latvian Medicines Verification Organization.

The customer satisfaction survey conducted by the Latvian Medicines Verification Organization (LZVO) received a high evaluation for its customer service.

Last year residents of Latvia received only safe prescription medicine, checked at the end of legal supply chain – pharmacies and healthcare institutions. More than 26.2 million of packages have been verified for the authenticity by the medicine verification system.

On February 9 marks the third anniversary of a medicines verification system across Europe, including Latvia, that ensures patient safety by detecting falsified medicines in the legal supply chain.

To improve the quality of work and cooperation with customers, in November 2021 the Latvian Medicines Verification Organisation (LZVO) conducted a survey of Software Suppliers (SWS) about LZVO customer service.